Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
Authors:
Open Access
- 26 January 2016
- journal article
- review article
- Published by Springer Nature in Drugs & Therapy Perspectives
- Vol. 32 (3) , 119-130
Abstract
Severe infection of infants with respiratory syncytial virus (RSV) is a leading cause of morbidity in the developed world and mortality in the developing world. Prophylaxis using palivizumab in infants at risk for severe RSV disease reduces the rate of hospitalisation in this population of children. To ensure complete prophylaxis, infants must receive monthly doses over the winter season. To improve parental convenience, the Synacare® programme was implemented in Ireland and the Netherlands. Synacare® is now a longstanding programme in which palivizumab is administered in the home setting by skilled nurses. Protocols and procedures described here illustrate the efficiency and acceptability of the home delivery service of RSV disease prophylaxis. Post-administration surveys have indicated a high level of parental satisfaction with the programme. At-home paediatric programmes like Synacare® may serve as an alternative to burdensome monthly hospital visits and may lead to enhanced clinical outcomes.Keywords
Funding Information
- AbbVie Inc.
This publication has 40 references indexed in Scilit:
- Latitudinal Variations in Seasonal Activity of Influenza and Respiratory Syncytial Virus (RSV): A Global Comparative ReviewPLOS ONE, 2013
- The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and DiseaseAmerican Journal of Epidemiology, 2012
- The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionalsPharmacoepidemiology and Drug Safety, 2011
- Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter studyClinical Epidemiology, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Cost comparison study of two different follow-up protocols after surgery for oesophageal cancerEuropean Journal of Cancer, 2009
- The Burden of Respiratory Syncytial Virus Infection in Young ChildrenNew England Journal of Medicine, 2009
- Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemicsEuropean Journal of Pediatrics, 2007
- Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart diseaseThe Journal of Pediatrics, 2003
- Respiratory syncytial virus epidemics: the ups and downs of a seasonal virusThe Pediatric Infectious Disease Journal, 2003